Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in Pediatric Subjects (10 to 17 Years of Age) in the Treatment of Depressive Episodes Associated With Bipolar I Disorder

NCT04777357 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04777357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04777357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in Pediatric Subjects (10 to 17 Years of Age) in the Treatment of Depressive Episodes Associated With Bipolar I Disorder
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Recruiting
Start date
April 28, 2021
Completion date
March 31, 2027
Enrollment
380 (estimated)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder, depression